Quest Diagnostics, Inc. (DGX) Reports In-Line Q3 EPS; Lowers FY12 Outlook
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $235.02 +1.68%
Revenue Growth %: +7.8%
Financial Fact:
Total non-operating expenses, net: -33M
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: +7.8%
Financial Fact:
Total non-operating expenses, net: -33M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q3 EPS of $1.18, in-line with the analyst estimate of $1.18. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.91 billion.
Sees FY2012 EPS of $4.45-4.55, versus prior guidance of $4.45-4.60 and the consensus of $4.57. Revenues to grow approximately 0.5%, compared to the prior outlook of between 1% and 2%.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Sees FY2012 EPS of $4.45-4.55, versus prior guidance of $4.45-4.60 and the consensus of $4.57. Revenues to grow approximately 0.5%, compared to the prior outlook of between 1% and 2%.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
